MedPath

Randomized controlled trial of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug.

Not Applicable
Recruiting
Conditions
Malignant glioma
Registration Number
JPRN-UMIN000044326
Lead Sponsor
Hirosaki University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1)Deep coma 2)Uncontrollable Diabetes mellitus 3)Heavy liver dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath